MedPath

Candesant Biomedical, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating

Not Applicable
Completed
Conditions
Primary Axillary Hyperhidrosis
First Posted Date
2020-10-23
Last Posted Date
2023-09-07
Lead Sponsor
Candesant Biomedical, Inc.
Target Recruit Count
120
Registration Number
NCT04599907
Locations
🇺🇸

CA Dermatology & Clinical Research Inst, Encinitas, California, United States

🇺🇸

Center for Dermatology Clinical Research, Fremont, California, United States

🇺🇸

Grekin Skin Institute, Warren, Michigan, United States

and more 6 locations
© Copyright 2025. All Rights Reserved by MedPath